IE
TYRA icon

Israel Englander’s Tyra Biosciences TYRA Stock Holding History

Israel Englander’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$799K Sell
25,000
-15,000
-38% -$496K ﹤0.01% 4472
2026
Q1 		$1.53M Buy
+40,000
New +$1.29M ﹤0.01% 4094

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Israel Englander's TYRA Position: Q2 2026 in Review

Israel Englander reduced its Tyra Biosciences (TYRA) stake by 20% in Q2 2026, selling an estimated $1.45M and leaving 177,672 shares worth $5.67M. The position accounts for ﹤0.01% of the portfolio, ranked #2873.

Israel Englander first reported a position in TYRA in Q3 2021 and has held it in 12 quarters since. The position peaked at $8.49M in Q1 2026. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Israel Englander held 177,672 shares of Tyra Biosciences worth $5.67M as of Q2 2026.
  • Israel Englander sold 43,909 Tyra Biosciences shares in Q2 2026, an estimated $1.45M.
  • Tyra Biosciences made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2873 holding.
  • Israel Englander first reported a position in Tyra Biosciences in Q3 2021 and has held it in 12 quarters since.
  • Israel Englander's Tyra Biosciences position peaked at $8.49M in Q1 2026.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.